In Brief Linda Fleisher receives Academy of Oncology Nurse & Patient Navigators Lifetime Achievement Award February 04, 2022Vol.48 No.05
Trials & Tribulations Leveraging cutting-edge technology to address the impact of COVID-19 on cancer screening, diagnosis, and treatment February 04, 2022Vol.48 No.05By Gustaf Salford
Clinical Roundup President’s Cancer Panel calls for improved equity and access as cancer screening rates lag February 04, 2022Vol.48 No.05
Clinical Roundup UAB study supports virotherapy as a potential treatment for glioblastoma February 04, 2022Vol.48 No.05
Clinical Roundup Yale study explores treatment for advanced triple-negative breast cancer February 04, 2022Vol.48 No.05
Drugs & Targets FDA investigating possible increased risk of death with lymphoma drug Ukoniq February 04, 2022Vol.48 No.05
Drugs & Targets Veru, Eli Lilly to evaluate enobosarm + Verzenio in phase III ENABLAR-2 trial February 04, 2022Vol.48 No.05
St. Jude, WHO tell us how their $200M initiative would fix global drug shortages for kids with cancer—and (maybe) adults January 28, 2022Vol.48 No.04By Matthew Bin Han Ong
Conversation with The Cancer Letter St. Jude’s James Downing: The solution for drug shortages isn’t regional—it has to be global January 28, 2022Vol.48 No.04By Matthew Bin Han Ong
